X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4564) 4564
Publication (295) 295
Book Review (148) 148
Book Chapter (30) 30
Magazine Article (28) 28
Conference Proceeding (5) 5
Book / eBook (4) 4
Data Set (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Trade Publication Article (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2905) 2905
index medicus (2823) 2823
rivaroxaban (2321) 2321
administration, oral (1907) 1907
warfarin (1875) 1875
anticoagulants (1832) 1832
dabigatran (1783) 1783
atrial fibrillation (1482) 1482
anticoagulants - therapeutic use (1268) 1268
anticoagulants - administration & dosage (1249) 1249
apixaban (1180) 1180
female (1068) 1068
male (1065) 1065
stroke (1049) 1049
anticoagulants - adverse effects (1032) 1032
venous thromboembolism (935) 935
aged (927) 927
oral anticoagulants (905) 905
cardiac & cardiovascular systems (867) 867
atrial fibrillation - drug therapy (863) 863
hematology (858) 858
thromboembolism (770) 770
peripheral vascular disease (766) 766
prevention (725) 725
stroke - prevention & control (716) 716
risk factors (704) 704
middle aged (700) 700
hemorrhage - chemically induced (685) 685
treatment outcome (684) 684
atrial-fibrillation (653) 653
direct oral anticoagulants (616) 616
atrial fibrillation - complications (606) 606
safety (572) 572
pharmacology & pharmacy (554) 554
management (553) 553
risk (526) 526
stroke prevention (512) 512
bleeding (497) 497
medicine, general & internal (484) 484
anticoagulation (466) 466
dabigatran etexilate (464) 464
thrombosis (464) 464
aged, 80 and over (461) 461
therapy (430) 430
cardiac arrhythmia (420) 420
patients (408) 408
stroke - etiology (401) 401
analysis (386) 386
edoxaban (385) 385
factor xa inhibitors (383) 383
antithrombotic therapy (378) 378
drug therapy (373) 373
warfarin - therapeutic use (370) 370
care and treatment (369) 369
pyridones - therapeutic use (365) 365
pyrazoles - therapeutic use (364) 364
abridged index medicus (362) 362
vitamin k - antagonists & inhibitors (361) 361
blood coagulation - drug effects (339) 339
factor xa inhibitor (335) 335
thrombin (333) 333
medicine & public health (332) 332
adult (331) 331
venous thromboembolism - drug therapy (324) 324
efficacy (318) 318
rivaroxaban - therapeutic use (315) 315
deep-vein thrombosis (313) 313
pyridones - administration & dosage (313) 313
pyrazoles - administration & dosage (312) 312
cardiology (306) 306
metaanalysis (304) 304
retrospective studies (302) 302
hemorrhage (301) 301
morpholines - therapeutic use (300) 300
risk assessment (300) 300
thiophenes - therapeutic use (299) 299
beta-alanine - analogs & derivatives (295) 295
dosage and administration (290) 290
oral anticoagulation (289) 289
rivaroxaban - administration & dosage (284) 284
thiophenes - administration & dosage (284) 284
morpholines - administration & dosage (283) 283
mortality (281) 281
double-blind (275) 275
clinical trials (272) 272
pharmacokinetics (271) 271
venous thromboembolism - prevention & control (269) 269
warfarin - adverse effects (265) 265
aspirin (261) 261
surgery (256) 256
anticoagulants - pharmacology (255) 255
direct thrombin inhibitor (252) 252
thromboembolism - prevention & control (250) 250
research (249) 249
factor-xa inhibitor (245) 245
warfarin - administration & dosage (245) 245
pulmonary embolism (244) 244
rivaroxaban - adverse effects (242) 242
time factors (242) 242
fibrillation (240) 240
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4130) 4130
German (139) 139
French (85) 85
Spanish (76) 76
Russian (54) 54
Japanese (39) 39
Italian (20) 20
Portuguese (16) 16
Hungarian (12) 12
Czech (11) 11
Polish (10) 10
Dutch (3) 3
Turkish (3) 3
Chinese (2) 2
Korean (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 05/2014, Volume 129, Issue 18, pp. 1850 - 1859
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 11/2016, Volume 116, Issue 5, pp. 975 - 986
In addition to warfarin, there are four non-vitamin K antagonist oral anticoagulants (NOACs) available for stroke prevention in non valvular atrial... 
Rivaroxaban | Warfarin | Dabigatran | Non-valvular atrial fibrillation | Major bleeding | Apixaban | EFFICACY | SAFETY | rivaroxaban | apixaban | ASPIRIN | warfarin | STROKE | major bleeding | ORAL ANTICOAGULANTS | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
Circulation, ISSN 0009-7322, 07/2014, Volume 130, Issue 2, pp. 138 - 146
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism;... 
MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | THERAPY | DISEASE | PREVENTION | DEEP-VEIN THROMBOSIS | IDRAPARINUX | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article